Phase 2 Alopecia Areata Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Men between 18 and 55 years of age
• People diagnosed with male-pattern baldness rated at a specific severity level known as Norwood-Hamilton grade III, IV, or V (confirm with trial site for clarification on grading)
• People whose hair loss pattern has remained stable for at least 6 months before the initial screening appointment
• People willing to avoid all other hair loss treatments during the study and for 6 months after the treatment period ends

Who may not be able to join:

• People with other types of hair loss conditions, such as patchy hair loss (alopecia areata), scarring hair loss (cicatricial alopecia), or temporary shedding-related hair loss (telogen effluvium)
• People who have used hair loss medications such as minoxidil, finasteride, or spironolactone within the past year before screening
• People who have had scalp procedures such as platelet-rich plasma (PRP) injections, laser cap therapy, or similar treatments within the past 6 months before screening
• People with a history of autoimmune disease, an active scalp infection, blood clotting disorders, or cancer
• People with a known allergy or sensitivity to the study treatment or any of its ingredients
• People who may have difficulty following the study procedures or whose condition could affect how results are measured (confirm with trial site)
• People currently participating in another clinical trial
• People considered unsuitable for the study by the supervising medical investigator, for any reason

Important: Always verify eligibility with the trial site directly before applying.